View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Marine Leleux ... (+3)
  • Marine Leleux
  • Maureen Schuller
  • Suvi Platerink Kosonen

Bank Brunch/NIBC and Tier 2 thoughts, covered bond supply

A sale of NIBC could open up some potential for Tier 2 outperformance; Slowdown in Covered bond supply after four weeks of heavy activity

Marine Leleux ... (+3)
  • Marine Leleux
  • Maureen Schuller
  • Suvi Platerink Kosonen

Bank Brunch/NIBC and Tier 2 thoughts, covered bond supply

A sale of NIBC could open up some potential for Tier 2 outperformance; Slowdown in Covered bond supply after four weeks of heavy activity

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

B&S: Sarabel launches recommended all cash offer; Belgian Telecoms: Digi confirms possible minority stake disposal in Spain; market test for Flanders cooperation agreement due any time; Exor: Great companies outperforming the benchmark; PostNL: Feedback on Capital Markets Day event 2025 - new strategy and ambitions 2028; UCB: Encouraging P2a data for Galvokimig in Atopic Dermatitis; Wolters Kluwer: Accelerating share buyback programme and good start to 2H25

Jan Frederik Slijkerman ... (+5)
  • Jan Frederik Slijkerman
  • Jeroen van den Broek
  • Jesse Norcross
  • Nadège Tillier
  • Timothy Rahill

Coffee, Croissants & Credit/Inmobiliaria Colonial, Benelux TMT Credits

Real Estate: Inmobiliaria Colonial was back in the market with a green bond; TMT: Benelux TMT Credits - How's it going? Where's the value?

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ASML: Chinese advanced DUV machine on trial; Azelis: Muddling through 2025 PostNL: CMD - new strategy and ambitions for 2028; Proximus: New CEO of Proximus Global announced Syensqo: CEO succession; UCB: Brivekimig (Sanofi) P2a results in Hidradenitis Suppurativa

Jan Frederik Slijkerman
  • Jan Frederik Slijkerman

Benelux TMT Credits: How's it going? Where's the value?

These are exciting times in the Benelux TMT markets. In this new Benelux Credit TMT report we discuss the most attractive corporate bonds in the Benelux and wider TMT space and provide insights into the key developments driving the Dutch broadband market. We also discuss recent developments of the names under our coverage: ASML, SES, KPN, Proximus, VodafoneZiggo, Telenet, Wolters Kluwer and RELX. The latter section comes from previously published Flash Notes and have been updated where needed.

Daimler Truck : Sustainability Weekly 8 - 12 September 2025

Last week, we published a report in which we propose ideas on the theme of sustainable sovereignty. Technip Energies signed an agreement to acquire the Advanced Materials & Catalysts business of Ecovyst Inc, a global leader in specialty catalysts and advanced materials. The IEA is expected to reintroduce its slow transition scenario, ‘Current Policies’, in its next World Energy Outlook, probably under pressure from the Trump administration. German Chancellor Merz has hinted at a slowdown in the ...

Daimler Truck : Sustainability Weekly 8 – 12 septembre 2025

La semaine passée, nous avons publié une étude où nous proposons des idées pour la thématique de la souveraineté durable. Technip a signé un accord en vue d'acquérir l'activité Advanced Materials & Catalysts d'Ecovyst Inc, leader mondial des catalyseurs spéciaux et des matériaux avancés. L'AIE devrait réintroduire son scénario de transition lente « Current Policies » dans son prochain World Energy Outlook, probablement sous la pression de l'administration Trump. Le chancelier allemand Merz a lai...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Belgian telcos: Football rights negotiations between DAZN and Proximus resume. Eurocommercial Properties: CMD Feedback. EVS: Adds another small acquisition to its new ‘media robotics' segment. Kinepolis: Paramount Skydance reportedly to bid for Warner Bros. Discovery. Wolters Kluwer: Two CEOs, one strong AI story

 PRESS RELEASE

Euronext to join the CAC 40® Index

Euronext to join the CAC 40® Index Euronext to join the CAC 40® Index Euronext celebrates recognition of strong market performance and shareholder value creation since the IPO in 2014 Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 12 September 2025 – Euronext, the leading European capital market infrastructure, is proud to highlight its upcoming inclusion in the CAC 40® Index (PX1), following the quarterly review of the CAC® Family indices performed by the Scientific Committee. Euronext’s entry into the benchmark French index will take place after market close on Friday 19 S...

 PRESS RELEASE

ABN AMRO completes EUR 250 million share buyback programme

ABN AMRO completes EUR 250 million share buyback programme ABN AMRO completes EUR 250 million share buyback programme 11 September 2025 ABN AMRO announced today that it has completed its EUR 250 million share buyback programme which started on 7 August 2025. Under the share buyback programme a total of 9,847,302 ordinary shares and depository receipts were purchased, representing 1.18% of issued shares, at an average price of EUR 25.39. ABN AMRO intends to cancel the repurchased ordinary shares and corresponding depository receipts in due course. NLFI as a majority shareholder has parti...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Azelis: Highlights ING Benelux Conference London. Barco: Highlights ING Benelux Conference London. Kinepolis: Highlights ING Benelux Conference London. Melexis: Highlights ING Benelux Conference London. ABN AMRO: Dutch State reducing stake to 20%. ASML: x Mistral, a bet on A.I.. Kinepolis: Cineplex August 2025 box office revenue at 87% of 2019 level, down 27% YoY

 PRESS RELEASE

Euronext announces volumes for August 2025

Euronext announces volumes for August 2025 Euronext announces volumes for August 2025         Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 8 September 2025 – Euronext, the leading European capital market infrastructure, today announced trading volumes for August 2025. Monthly and historical volume tables are available at this address: CONTACTS   ANALYSTS & INVESTORS – Investor Relations        Judith Stein         97           MEDIA –   Europe        Andrea Monzani          13         Sandra Machado          7 Belgium        Marianne Aalders          France, ...

 PRESS RELEASE

Progress on ABN AMRO share buyback programme 29 August – 4 September 2...

Progress on ABN AMRO share buyback programme 29 August – 4 September 2025 Progress on ABN AMRO share buyback programme 29 August – 4 September 2025 ABN AMRO reports the transaction details related to its EUR 250 million share buyback programme announced on 6 August 2025.During the week of 29 August 2025 up to and including 4 September 2025 a total of 2,000,000 shares and depositary receipts were repurchased at an average price of €24.82 for a total amount of € 49,646,240.For detailed information on the daily repurchased shares and depositary receipts, individual share purchase transactions...

 PRESS RELEASE

Ackermans & van Haaren supports MRM Health’s Series B financing round ...

Ackermans & van Haaren supports MRM Health’s Series B financing round of 55 million euros Dear shareholder, Dear Madam, Dear Sir, Ackermans & van Haaren (AvH) supports the Series B financing round totaling 55 million euros of MRM Health, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology. For AvH, this series B financing round involves an additional investment of 3 million euros and brings its total investment in MRM Health to 10.8 million euros and its fully diluted participation to 14.1%. Please find the ...

 PRESS RELEASE

Ackermans & van Haaren soutient le tour de financement de série B de 5...

Ackermans & van Haaren soutient le tour de financement de série B de 55 millions d’euros de MRM Health Cher actionnaire, Monsieur, Madame, Ackermans & van Haaren (AvH) soutient le tour de financement de Série B totalisant 55 millions d’euros de MRM Health, une société biopharmaceutique en phase clinique, pionnière dans les thérapeutiques basées sur le microbiome pour les maladies inflammatoires et l’immuno-oncologie. Pour AvH, ce tour de financement de Série B comprend un investissement supplémentaire de 3 millions d'euros, ce qui porte l'investissement total d'AvH dans MRM Health à 10...

 PRESS RELEASE

Ackermans & van Haaren ondersteunt de serie B-financieringsronde van 5...

Ackermans & van Haaren ondersteunt de serie B-financieringsronde van 55 miljoen euro van MRM Health Geachte aandeelhouder, Geachte mevrouw, geachte heer, Ackermans & van Haaren (AvH) ondersteunt de serie B-financieringsronde van in totaal 55 miljoen euro van MRM Health, een biofarmaceutisch bedrijf in de klinische fase dat pioniert met therapieën op basis van het microbioom voor inflammatoire aandoeningen en immuun-oncologie. Voor AvH omvat deze serie B-financieringsronde een aanvullende investering van 3 miljoen euro, waarmee de totale investering van AvH in MRM Health op 10,8 miljoen...

 PRESS RELEASE

Euronext announces share repurchase programme as part of its long-term...

Euronext announces share repurchase programme as part of its long-term incentive plan    Euronext announces share repurchase programme as part of its long-term incentive plan         Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 3 September 2025 – Euronext today announced that it will repurchase 101,000 of its own shares as part of its Long-Term Incentive plans. This repurchase programme will be implemented and directed by an independent agent during the period commencing on 4 September 2025 (including) and ending no later than 6 October 2025 (including). This programme...

Lynn Hautekeete
  • Lynn Hautekeete
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch